Jack A. Khattar Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

SUPN Quotes by TradingView

Jack A. Khattar is President, CEO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.21 Million shares of SUPN, which is worth approximately $54.3 Million. The most recent transaction as insider was on Oct 09, 2025, when has been sold 59,900 shares (Common Stock) at a price of $51.0 per share, resulting in proceeds of $3,054,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.21M
12.61% 3M change
30.28% 12M change
Total Value Held $54.3 Million

Jack A. Khattar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2025
SELL
Open market or private sale
$3,054,900 $51.0 p/Share
59,900 Reduced 4.73%
1,206,578 Common Stock
Oct 09 2025
BUY
Exercise of conversion of derivative security
$2,055,625 $25.3 p/Share
81,250 Added 6.03%
1,266,478 Common Stock
Oct 02 2025
SELL
Payment of exercise price or tax liability
$708,168 $46.21 p/Share
15,325 Reduced 1.28%
1,185,228 Common Stock
Oct 02 2025
SELL
Open market or private sale
$91,506 $48.06 p/Share
1,904 Reduced 0.16%
1,161,233 Common Stock
Oct 02 2025
BUY
Exercise of conversion of derivative security
-
39,320 Added 3.19%
1,192,757 Common Stock
Oct 02 2025
BUY
Exercise of conversion of derivative security
$57,355 $25.3 p/Share
2,267 Added 0.19%
1,163,137 Common Stock
Oct 01 2025
SELL
Open market or private sale
$1,931,116 $48.07 p/Share
40,173 Reduced 3.34%
1,160,870 Common Stock
Oct 01 2025
BUY
Exercise of conversion of derivative security
$1,360,760 $25.3 p/Share
53,785 Added 4.29%
1,201,043 Common Stock
Sep 30 2025
SELL
Open market or private sale
$414,371 $48.25 p/Share
8,588 Reduced 0.74%
1,147,258 Common Stock
Sep 30 2025
BUY
Exercise of conversion of derivative security
$291,203 $25.3 p/Share
11,510 Added 0.99%
1,155,846 Common Stock
Sep 29 2025
SELL
Open market or private sale
$491,484 $48.02 p/Share
10,235 Reduced 0.89%
1,144,336 Common Stock
Sep 29 2025
BUY
Exercise of conversion of derivative security
$346,306 $25.3 p/Share
13,688 Added 1.17%
1,154,571 Common Stock
Sep 23 2025
SELL
Open market or private sale
$1,393,898 $47.23 p/Share
29,513 Reduced 2.52%
1,140,883 Common Stock
Sep 23 2025
BUY
Exercise of conversion of derivative security
$622,261 $12.98 p/Share
47,940 Added 3.93%
1,170,396 Common Stock
Sep 22 2025
SELL
Open market or private sale
$779,920 $47.02 p/Share
16,587 Reduced 1.46%
1,122,456 Common Stock
Sep 22 2025
BUY
Exercise of conversion of derivative security
$351,238 $12.98 p/Share
27,060 Added 2.32%
1,139,043 Common Stock
Sep 08 2025
SELL
Open market or private sale
$292,645 $46.29 p/Share
6,322 Reduced 0.57%
1,111,983 Common Stock
Sep 08 2025
BUY
Exercise of conversion of derivative security
$204,272 $25.3 p/Share
8,074 Added 0.72%
1,118,305 Common Stock
Sep 05 2025
SELL
Open market or private sale
$2,557,143 $46.01 p/Share
55,578 Reduced 4.77%
1,110,231 Common Stock
Sep 05 2025
BUY
Exercise of conversion of derivative security
$1,851,352 $25.3 p/Share
73,176 Added 5.91%
1,165,809 Common Stock
Aug 28 2025
SELL
Open market or private sale
$1,089,648 $45.12 p/Share
24,150 Reduced 2.16%
1,092,633 Common Stock
Aug 28 2025
BUY
Exercise of conversion of derivative security
$503,351 $12.98 p/Share
38,779 Added 3.36%
1,116,783 Common Stock
Aug 27 2025
SELL
Open market or private sale
$479,782 $45.05 p/Share
10,650 Reduced 0.98%
1,078,004 Common Stock
Aug 27 2025
BUY
Exercise of conversion of derivative security
$223,191 $12.98 p/Share
17,195 Added 1.55%
1,088,654 Common Stock
Aug 25 2025
SELL
Open market or private sale
$45,000 $45.0 p/Share
1,000 Reduced 0.09%
1,071,459 Common Stock

Also insider at

SCPH
scPharmaceuticals Inc. Healthcare
CGTX
COGNITION THERAPEUTICS INC Healthcare
Director
JAK

Jack A. Khattar

President, CEO
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SUPN